CD38 and inflammatory bowel disease: In this sense, a recent proteomic analysis of intestinal tissue from healthy controls and patients with IBD, revealed upregulation of proteins related to NAD+ metabolism, including CD38, suggesting that CD38’s NADase activity contributes to modulate NAD+ levels during IBD.